Hepcdac 60mg
| SKU | 2153 |
|---|---|
| Generic For | Daklinza |
| Strength | 60mg |
| Active Ingredient | Daclatasvir |
Out Of Stock
Hepcdac 60mg (Daclatasvir) – Affordable Daklinza Alternative
Hepcdac 60 mg, a product by Cipla, is an antiviral medication specially formulated for the treatment of chronic hepatitis C viral infection, a viral infection of the liver. The active ingredient of the medicine is Daclatasvir, which is active against hepatitis C virus. The medicine is used to reduce the amount of hepatitis C virus in your body and helps the immune system to fight the infection. Hepcdac is prescribed in combination with another antiviral medicine called ribavirin to help the liver recover from this viral infection. Daclatasvir is a prescription medicine which should be used under the supervision of a health care specialist.
Clinical Uses of Hepcdac 60 mg
Hepcdac, is a generic version of the drug Daclatasvir. The antiviral agent is mainly indicated for the treatment of chronic hepatitis C viral infection in adults. It exhibits antiviral activity against genotype I and III induced hepatitis C viral infection. The drug prevents the hepatitis C virus from multiplying in the body. It needs to be administered along with other antiviral drugs for the best results.
Dosing Instructions and Method of Administration
As mentioned above, Hepcdac may be prescribed alone or in combination with another antiviral drug. The medicine is available in the form of tablets that are administered before or after consuming food. The recommended dose for the treatment of chronic hepatitis C infection is one tablet of 60 mg taken once in a day with water. The antiviral tablets are prescribed to patients with genotype I or III HCV infection. In general, the duration of the treatment is 12 weeks. Take it daily to achieve the maximum benefits. This leaflet contains the general information associated with the use of Hepcdac 60 mg tablet. It is wise to take Daclatasvir exactly as your health care specialist says as the dose should be determined by the health care specialist based on your age, overall medical history, and current health status. You are not allowed to change the dosing pattern without first talking to your health care provider.
Side Effects of Hepcdac Tablet
In addition to its benefits, Hepcdac may cause side effects too. On using this antiviral medication, you may experience side effects such as weakness, nausea, fatigue, breakdown, diarrhea, skin rash, If the unwanted effects persist or become worse over time, take the help of your health care specialist. This is not the completes list of side effects, if you notice any other unwanted effect associated with the use of Daclatasvir, contact your health care provider.
Before using this antiviral drug, be sure to tell your health care specialist if you are allergic to Daclatasvir, you are taking any other medication including prescription, non-prescription, vitamins, and supplements, you have heart, liver, or kidney disorders, or you are pregnant or planning to become pregnant. If you are a nursing mother, please consult your health care specialist before consuming the drug because it is unknown if the medicine passes into the breast milk.
What is Daclatasvir and what condition does it treat?
Daclatasvir is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection. Available as Hepcdac 60mg, this direct-acting antiviral agent belongs to the NS5A inhibitor class of hepatitis C treatments. Daclatasvir works by blocking a specific protein the virus needs to multiply, helping your body clear the infection. It's typically prescribed in combination with other antivirals like sofosbuvir to treat different genotypes of hepatitis C. This HCV medicine has proven effective in achieving sustained virologic response, meaning the virus becomes undetectable in your blood after completing the treatment course.
How does Daclatasvir work in the body to fight hepatitis C?
Daclatasvir functions as an NS5A replication complex inhibitor, targeting a key stage in the hepatitis C virus lifecycle. When you take Hepcdac 60mg, the active ingredient daclatasvir binds to the NS5A protein that HCV requires for viral replication and assembly. By blocking this essential protein, the antiviral prevents the virus from copying itself and forming new infectious particles. This mechanism stops the hepatitis C virus from spreading to healthy liver cells. Unlike older interferon-based treatments, daclatasvir offers a more targeted approach with fewer systemic side effects, making it a preferred option in modern HCV therapy regimens.
How long does Hepcdac 60mg take to work against hepatitis C?
Hepcdac 60mg starts working within hours of your first dose, but noticeable results take longer. Most patients see significant viral load reduction within the first four weeks of treatment with this daclatasvir-based antiviral regimen. Complete treatment typically lasts 12 to 24 weeks depending on your hepatitis C genotype, liver condition, and whether you've tried HCV medications before. Your doctor will monitor your viral levels through regular blood tests during therapy. The ultimate goal—sustained virologic response where the virus remains undetectable 12 weeks after finishing treatment—determines success. Many patients achieve cure rates exceeding 90% when completing the full prescribed course.
When and how should I take Hepcdac 60mg for best results?
Take Hepcdac 60mg once daily at the same time each day, with or without food. Swallow the tablet whole with water—don't crush, chew, or split it. Consistency matters with this daclatasvir antiviral, so setting a daily reminder helps maintain steady medication levels in your bloodstream. If you miss a dose and it's within 12 hours of your usual time, take it immediately; beyond that window, skip the missed dose and resume your normal schedule. Always inform your doctor about all medications you're currently taking, as some drugs can interact with this NS5A inhibitor and require dose adjustments.
Is Hepcdac 60mg safe for long-term use in hepatitis C treatment?
Hepcdac 60mg is designed for finite treatment courses, not indefinite long-term use. Standard daclatasvir therapy for chronic hepatitis C typically lasts 12 to 24 weeks, after which most patients achieve sustained viral clearance and discontinue the medication. Clinical studies demonstrate this NS5A inhibitor antiviral is well-tolerated during these treatment periods with manageable side effects. Unlike older interferon-based regimens that caused severe long-term complications, modern direct-acting antivirals like daclatasvir offer safer profiles. Once you complete treatment and achieve cure, ongoing antiviral therapy isn't necessary. Your healthcare provider monitors liver health post-treatment to ensure the virus remains undetectable.
Can I take Hepcdac 60mg with other medicines or supplements?
Hepcdac 60mg can interact with numerous medications, so comprehensive disclosure to your healthcare provider is essential. This daclatasvir-based antiviral shouldn't be combined with certain heart medications, antibiotics, antifungals, seizure medicines, or St. John's Wort, as these can reduce effectiveness or increase side effects. Acid-reducing medications may also affect absorption of your hepatitis C treatment. The dose of Hepcdac may need adjustment if you're taking specific drugs. Your prescriber will review your complete medication list, including over-the-counter products and herbal supplements, before starting this NS5A inhibitor to ensure safe combination therapy.
How does Hepcdac 60mg compare to other hepatitis C medicines?
Hepcdac 60mg, containing daclatasvir, belongs to the NS5A inhibitor category alongside medications like ledipasvir and velpatasvir. Compared to these similar antivirals, daclatasvir offers broad genotype coverage and flexible combination options, particularly with sofosbuvir. While single-tablet combination therapies offer convenience, separate daclatasvir tablets like Hepcdac provide dosing flexibility for patients with specific medical considerations or those requiring dose adjustments. Cure rates are comparable across modern direct-acting antivirals when properly matched to your hepatitis C genotype. Unlike older interferon treatments, all current NS5A inhibitors including Hepcdac demonstrate superior tolerability, shorter treatment duration, and significantly higher success rates in eliminating the virus.
Is generic Daclatasvir as effective as branded versions for hepatitis C?
Generic daclatasvir, including Hepcdac 60mg, contains the identical active ingredient as the original branded version and delivers equivalent therapeutic effectiveness. Regulatory authorities require generic manufacturers to prove bioequivalence—meaning the medication achieves the same blood concentration levels and clinical outcomes as brand-name products. Generic NS5A inhibitors undergo rigorous quality testing to ensure they meet the same safety and efficacy standards. The primary difference lies in price, not performance. Many hepatitis C patients choose quality generics like Hepcdac for substantial cost savings without compromising treatment success. Clinical response rates for generic and branded daclatasvir remain virtually identical across patient populations.
Why do patients choose PremiumRxDrugs for Hepcdac 60mg purchases?
Patients select PremiumRxDrugs for Hepcdac 60mg because of consistently competitive pricing on this medication, making effective antiviral treatment more affordable. As a fully licensed international pharmacy with over ten years of experience serving customers, we guarantee authentic manufacturer-sourced NS5A inhibitors, eliminating concerns about counterfeit drugs. Our discreet packaging protects your privacy, while worldwide shipping with free delivery options makes access convenient regardless of location. The straightforward prescription management system simplifies refills for multi-week hepatitis C treatment courses. Patients across the USA, UK, Australia, and Canada appreciate the combination of medication authenticity, affordability, reliable delivery, and responsive customer support that PremiumRxDrugs consistently delivers.
What are the common side effects of Daclatasvir treatment?
Common side effects of daclatasvir include fatigue, headache, and nausea, though most people tolerate this NS5A inhibitor antiviral well. Some patients experience diarrhea, insomnia, or mild abdominal discomfort during hepatitis C therapy. When combined with sofosbuvir, the most frequent combination, tiredness and headache occur most often but usually remain manageable. Serious side effects are uncommon but may include significant heart rate changes, particularly in patients taking certain heart medications alongside this HCV treatment. Most side effects decrease as your body adjusts to the medication. Compared to older interferon-based hepatitis C regimens, daclatasvir-containing treatments produce substantially fewer and milder adverse reactions.
Who should avoid taking Daclatasvir for hepatitis C?
Daclatasvir isn't recommended if you're allergic to this NS5A inhibitor or any tablet ingredients. Patients taking certain medications that strongly interact with this antiviral—including specific heart rhythm drugs, seizure medications, or St. John's Wort—should avoid daclatasvir or use alternative hepatitis C treatments. Pregnant women and those planning pregnancy should discuss risks with their healthcare provider, as safety data remains limited. People with severe liver problems beyond hepatitis C may require careful evaluation before starting this HCV medication. If you have significant heart conditions, particularly bradycardia or heart block, your doctor will assess whether daclatasvir therapy is appropriate or requires additional cardiac monitoring during treatment.
Login
Sign Up
Login
Sign Up